InvestorQ : How do you see the quarterly results of Aurobindo Pharma for Sep-21 quarter?
Arusha Ray made post

How do you see the quarterly results of Aurobindo Pharma for Sep-21 quarter?

Answer
image
3 weeks ago
Follow

Actually Aurobindo Pharma faced pressure on top line and bottom line. It reported -8.4% lower sales for Sep-21 quarter at Rs.5,942 crore. However, the US formulations business grew 6.9% to Rs.2,968 crore while the Europe business saw sales grow 9.7% at Rs.1,662 crore. Top Line pressure came from emerging growth markets. API revenues were lower, but the sharp 71% fall in sales came from the anti-retroviral or ARV sales.

Net profits were down -13.7% at Rs.696.99 crore in Sep-21 quarter. EBITDA margins fell yoy basis from 21.3% to 20% largely on account of profit hit in the ARV business due to higher stocking last year. However, Aurobindo did 27 ANDA filings, 3 DMF filings and 62 formulation dossiers in Q2. NPM for Sep-21 quarter at 3.49% was lower than 5.45% in the yoy Sep-20 yoy quarter but higher than 3.05% in Jun-21 quarter.

0 Views